Durability of Tuberculosis Drug Increased through New Formulation - Genetic Engineering & Biotechnology News

Scientists at the University of North Carolina, Case Western University, and Duke University have developed a long-acting delivery system for the tuberculosis drug, rifabutin, that could increase compliance to treatment.

For the first time in more than a decade, the global death toll due to tuberculosis exceeded 1.5 million in 2020, underscoring the need for access to treatments that work better and last longer. Dur… [+4970 chars]

full article...